1887
Volume 1998, Issue 2
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

Abstract

A series is presented of 30 patients with generalized myasthenia gravis (MG) who were treated by sternal split and extended thymectomy. The mean age was 22 years, median 19 years with a female to male ratio of 2:1. The overall improvement rate was 90%; 70% achieved drug-free remission and another 20% required decreased medication. Drug-free remission was achieved in 80% female and in 50% male and in 50% on steriods and mestinon compared with 80% of those on mestinon alone. There were no deaths or significant complications. These results suggest that an aggressive surgical approach to myasthenia gravis can result in a higher percentage of drug-free remissions.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.1998.2.9
2014-11-01
2019-10-19
Loading full text...

Full text loading...

References

  1. 1. Buckingham  I.M..,, Haward  F.M.., Bernatz  P.E..: The value of thymectomy in myasthenia gravis. . Ann Surg 184::1976:453.
    [Google Scholar]
  2. 2. Downald  G.., Mulder .,. Michael  Graves.,, Christian  Herrman.: Thymectomy for myasthenia gravis: Recent observations and compassions with past experience. . Ann Thorac Surg 48::1989:551–555.
    [Google Scholar]
  3. 3. Lindstrom  I.M..,, Seybold  M.E..,, Lennon  V.A.., Whittinghams .,, Dnane  DD.: Antibody to acteylcholine receptor in myasthenia gravis: prevalence Clinical correlates and diagnostic value. . Neurology. 26:: 1976:1054
    [Google Scholar]
  4. 4. Drachman  D.B..,, Adams  R.N..,, Josifek  E.E..,, Self  S.G..: Functional activities of autoantibodies to anti acteylcholine receptors and the clinical severity of myasthenia gravis. . N Engl J Med 307:: 1982:769.
    [Google Scholar]
  5. 5. Kao  I..,, Drachman  D.B..: Myasthenic immunoglobulin accelerates acteylcholine receptor degradation. . Science 196::1977:527.
    [Google Scholar]
  6. 6. Castelman  B..: The pathology of the thymus gland in myasthenia gravis. . Ann NY Acad ScL 135::1966:496.
    [Google Scholar]
  7. 7. Wekerle  H..: Muller - Hermelink HK: The thymus in myasthenia gravis. . Curr Tup Pathol 75:1986:179–206.
    [Google Scholar]
  8. 8. Fisher  Josef E..,, Grinvalski  Henry T..,, Nussbaun  Michael S..,, Sayers  Hezel J..,, Cole  Robert E..,, Samaha  Frederick J..: Aggressive surgical approach for drug free remission from Myasthenia Gravis. . Ann Surg May 1987:
    [Google Scholar]
  9. 9. William  Frist H..,, Shanti  Thirumalai.,, Christopher  Doehring B..: Thymectomy for the myasthenia gravis patient: Factors influencing outcome. . Ann Thorac Surg 57::1994:334–338.
    [Google Scholar]
  10. 10. Otto  T.J..,, Strugalska  H..: Surgical treatment for myasthenia gravis. . Thorax 42:: 1987:199–204.
    [Google Scholar]
  11. 11. Osterman  P.O..: Current treatment of myasthenia gravis. . Prog Brain Res 84:1990:151–161.
    [Google Scholar]
  12. 12. Beghi  E.,, Antozzi  C.,, Batocchi  A.P., et al. Prognosis of myasthenia gravis: A multic enter follow-up study of 844 patients. . J Neurol Sci 106::1991:213–220.
    [Google Scholar]
  13. 13. Jaretzki  A..,, Penn  A.S..,, Younger  DS.: Maximal thymectomy for myasthenia gravis. . J Thorac Cardiovasc Surg 95::1988:747–757.
    [Google Scholar]
  14. 14. Papatetas  A.E.,, Genkins  G.,, Kornfeld  P., et al. Effects of thymectomy in myasthenia gravis. . Ann Surg 206: 1987:79–88.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.1998.2.9
Loading
  • Article Type: Other
Keyword(s): Autoimmune , Drug Free Remission , Myasthenia Gravis and Thymectomy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error